North America Clinical Trials Support Services Market Forecast 2022-2030

The North America clinical trials support services market is set to grow with a 7.20% CAGR between the forecast period, 2022 and 2030. Efficient and cost-saving technologies and the presence of numerous market players boost the market growth in the region.

MARKET INSIGHTS

The North America clinical trials support services market growth analysis entails the evaluation of Canada and United States. Globally, Canada is known for the quality and expertise of its research clinicians. Some of them are globally recognized for major medical discoveries and innovations. The strong investments in the Canadian clinical trial process can also be attributed to Canada's world-leading higher education system, its publicly-funded health care system known for quality, etc.

Hundreds of new clinical trials are conducted in Canada about vaccines, medical drugs, etc. Further, children and youth can participate in the clinical trial process after seeking permission from their parents. Besides, the Canadian government funds the clinical trials through the Strategic Innovation Fund (SIF) to support research and development, clinical trials, and manufacturing vaccines and therapeutic drugs to fight COVID-19. Major global pharmaceutical companies conduct a large portion of their clinical trials in Canada, driving its growth during the forecast period.

COMPETITIVE INSIGHTS

Key players operating in the market include: IQVIA, Charles River Laboratories Inc, Parexel, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation caters to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 47753

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
- 3.1.2. BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
3.2. KEY RESTRAINTS
- 3.2.1. AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
- 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
- 4.7.1. PERFORMANCE
- 4.7.2. EASE OF USE
- 4.7.3. SECURITY
- 4.7.4. COST-EFFECTIVENESS
4.8. REGULATORY FRAMEWORK

5. MARKET BY PHASE

5.1. PHASE I
5.2. PHASE II
5.3. PHASE III
5.4. PHASE IV

6. MARKET BY SPONSOR

6.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
6.2. MEDICAL DEVICE COMPANIES
6.3. OTHER SPONSORS

7. MARKET BY SERVICE

7.1. CLINICAL TRIAL SITE MANAGEMENT
7.2. ADMINISTRATIVE STAFF
7.3. PATIENT RECRUITMENT MANAGEMENT
- 7.3.1. PATIENT RECRUITMENT & REGISTRY SERVICES
- 7.3.2. PATIENT RETENTION
- 7.3.3. OTHER PATIENT RECRUITMENT MANAGEMENT
7.4. IRB
7.5. DATA MANAGEMENT
7.6. OTHER SERVICES

8. GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. UNITED STATES
  - 8.1.5.2. CANADA

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ADVANCED CLINICAL
- 9.2.2. ALCURA
- 9.2.3. CHARLES RIVER LABORATORIES INC
- 9.2.4. CLINIPACE
- 9.2.5. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
- 9.2.6. ICON PLC
- 9.2.7. IQVIA
- 9.2.8. KCR
- 9.2.9. LABCORP DRUG DEVELOPMENT
- 9.2.10. MEDPACE
- 9.2.11. PAREXEL
- 9.2.12. PSI CRO
- 9.2.13. SYNEOS HEALTH
- 9.2.14. WORLDWIDE CLINICAL TRIALS
- 9.2.15. WUXI APPTEC

Product Code: 47753

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: LEADING PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 19: NUMBER AND TYPES OF REGISTERED STUDIES
TABLE 20: LIST OF MERGERS & ACQUISITIONS
TABLE 21: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 22: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 23: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 8: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)
FIGURE 10: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)
FIGURE 12: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 13: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 14: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 15: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)
FIGURE 16: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 17: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 18: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE STAFF, 2022-2030 (IN $ MILLION)
FIGURE 19: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 21: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 22: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)
FIGURE 23: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 24: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY IRB, 2022-2030 (IN $ MILLION)
FIGURE 25: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 26: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 27: NORTH AMERICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 28: UNITED STATES CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: CANADA CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)